M E8
Pill imprint M E8 has been identified as Estropipate 1.5 mg.
Estropipate is used in the treatment of oophorectomy; atrophic vaginitis; atrophic urethritis; primary ovarian failure; postmenopausal symptoms (and more), and belongs to the drug class estrogens. Not for use in pregnancy.
Estropipate 1.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Estropipate Images
- Imprint:
-
M E8
- Strength:
- 1.5 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-4553
More Estropipate resources
- Estropipate (Wolters Kluwer)
- estropipate (Cerner Multum)
- Estropipate (FDA)
- Estropipate (Piperazine Estrone Sulfate) (Wolters Kluwer)


